Medicare Enrolled
Dr. Gene Braga, M.D.
Urology Physician · Somers Point, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Braga from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Braga?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Braga
Dr. Gene Braga is an urology physician in Somers Point, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Braga performed 4,395 Medicare services across 3,320 unique beneficiaries.
Between the years covered by Open Payments, Dr. Braga received a total of $7,682 from 54 pharmaceutical and/or device companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Braga is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 35% volume in NJ
$7,682 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,395
Medicare services
Top 35% in NJ for urology physician
3,320
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~220 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,387 | $68 | $200 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
662 | $3 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
474 | $98 | $281 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
348 | $204 | $564 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
190 | $10 | $31 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
189 | $9 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
174 | $130 | $362 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
133 | $84 | $253 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
111 | $81 | $247 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
82 | $51 | $142 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
80 | $116 | $478 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
76 | $19 | $53 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
71 | $12 | $32 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
65 | $274 | $758 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
53 | $195 | $549 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
50 | $30 | $76 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
34 | $51 | $131 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 32 | $130 | $333 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
29 | $478 | $1,652 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
27 | $0 | $1 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
23 | $311 | $858 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
23 | $171 | $461 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
22 | $28 | $144 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
22 | $651 | $1,863 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
19 | $131 | $339 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
19 | $151 | $2,299 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,682
Total received (2018-2024)
Avg $1,097/year across 7 years
Top 17% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
436
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,156 (93.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$476 (6.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$50 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,206
2023
$1,837
2022
$1,636
2021
$1,097
2020
$846
2019
$564
2018
$495
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$395
Teleflex LLC
$146
Tolmar, Inc.
$128
Janssen Biotech, Inc.
$116
Bayer Healthcare Pharmaceuticals Inc.
$84
ABBVIE INC.
$46
Ferring Pharmaceuticals Inc.
$45
Antares Pharma, Inc.
$36
Blue Earth Diagnostics Limited
$36
Myriad Genetic Laboratories, Inc.
$34
Telix Pharmaceuticals
$31
Axonics, Inc.
$28
Astellas Pharma US Inc
$27
180 Medical, Inc.
$19
Novartis Pharmaceuticals Corporation
$19
Dendreon Pharmaceuticals LLC
$15
Top 3 companies account for 55.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$888
Astellas Pharma US Inc
$882
Sumitomo Pharma America, Inc.
$827
Teleflex LLC
$475
UROVANT SCIENCES INC
$411
PFIZER INC.
$398
AbbVie Inc.
$394
Myovant Sciences Inc.
$274
Myriad Genetic Laboratories, Inc.
$220
Bayer HealthCare Pharmaceuticals Inc.
$215
ABBVIE INC.
$208
Tolmar, Inc.
$172
AstraZeneca Pharmaceuticals LP
$169
Bayer Healthcare Pharmaceuticals Inc.
$152
Integra LifeSciences Corporation
$146
Axonics, Inc.
$144
Progenics Pharmaceuticals, Inc.
$134
180 Medical, Inc.
$123
Janssen Pharmaceuticals, Inc
$121
Antares Pharma, Inc.
$120
Dendreon Pharmaceuticals LLC
$114
Janssen Products, LP
$99
ConvaTec Inc.
$85
Ferring Pharmaceuticals Inc.
$72
Blue Earth Diagnostics Limited
$70
Merck Sharp & Dohme LLC
$65
Kowa Pharmaceuticals America, Inc.
$58
Medtronic, Inc.
$50
Telix Pharmaceuticals
$49
DENTSPLY IH AB
$42
Endo Pharmaceuticals Inc.
$35
UroGen Pharma, Inc.
$34
AbbVie, Inc.
$34
Photocure Inc
$32
Supernus Pharmaceuticals, Inc.
$32
NeoTract Inc.
$30
Amgen Inc.
$28
TOLMAR Pharmaceuticals, Inc.
$26
Clarus Therapeutics Inc.
$26
Coloplast Corp
$24
E.R. Squibb & Sons, L.L.C.
$22
Palette Life Sciences, Inc.
$20
Novartis Pharmaceuticals Corporation
$19
ACCORD HEALTHCARE, INC.
$17
C. R. BARD, INC. & SUBSIDIARIES
$16
Laborie Medical Technologies Corp.
$16
Verity Pharmaceuticals Inc.
$15
Merck Sharp & Dohme Corporation
$14
Mission Pharmacal Company
$13
DENTSPLY IH Inc.
$13
GENZYME CORPORATION
$12
Accord Healthcare, Inc.
$12
Avadel Specialty Pharmaceuticals, LLC
$12
Retrophin, Inc.
$1
Top 3 companies account for 33.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · Androgel · Axonics · Axonics r-SNM System · Axumin · Bulkamid · CAMCEVI · CEREC · Cysview · ELIGARD · ERLEADA · Erleada · GEMTESA · GENTLECATH · ILLUCCIX · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LOKELMA · LUPRON DEPOT · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · OMNIGRAFT · OPDIVO · ORGOVYX · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · SEGLENTIS · Seglentis · SpeediCath · TOVIAZ · Trelstar · UROLIFT · Uribel · UroLift · VESICARE · Veozah · XARELTO · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
31
Per 100K population
11.3
County median income
$76,819
Nearest hospital
SHORE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Braga is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Braga experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Braga performed 1,387 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Braga receive payments from pharmaceutical companies?
Yes. Dr. Braga received a total of $7,682 from 54 companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Braga's costs compare to other urology physicians in Somers Point?
Dr. Braga's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Braga) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Somers Point
Browse urology physicians in Somers Point ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology